Sycai Medical, based in Barcelona, has successfully raised €3M in funding, which will facilitate the development of their innovative AI-driven medical device aimed at early detection of cancerous lesions. The device utilizes advanced medical imaging to identify pancreatic, kidney, and liver cancers at early stages, minimizing the need for invasive procedures. Key backers include LUMO Labs, who praised the unique accuracy and scalability of Sycai's approach. The founding team's commitment to understanding the needs of healthcare practitioners has been vital in shaping their technology, showcasing their dedication to improving patient outcomes.
"We have looked at similar research and technologies across Europe and concluded that the accuracy, hardware-agnostic approach, and scalability of Sycai Medical is unmatched."
"Early diagnosis and targeted cures are key for the quality of life of a patient but also improve the circumstances for caregivers and even the efficiency of how our healthcare system is organised."
Collection
[
|
...
]